The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice
Behavioural Brain Research · 2023
DOI: 10.1016/j.bbr.2023.114399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Wei Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shang…. Hauptthemen laut MEDLINE: Antidepressive Agents, Bacteria, Depression, Gastrointestinal Microbiome. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai.
Themen: Depression
Abstract (Originalsprache)
Depression is associated with intestinal dysbiosis. Venlafaxine is a commonly used antidepressant in clinical practice as a serotonin and noradrenaline reuptake inhibitor. However, its effects on gut bacteria in depression remain unclear. Here, we established a mouse model of depression induced by chronic unpredictable mild stress (CUMS), and investigated the alterations of venlafaxine on the gut microbiota and potential key bacteria. Our data show that venlafaxine exerts antidepressant effects by restoring the serotonin (5-HT) system and glutamate (Glu) levels in CUMS mice. Moreover, we revealed that venlafaxine altered the diversity of gut bacteria in CUMS mice, and at genus level, Blautia, Oscillibacter, Tyzzerella, Butyricicoccus, and Enterorhabdus are the key bacteria responsible for venlafaxine-ameliorated depression in mice. Among these potential key bacteria, Blautia, Oscillibacter, and Butyricicoccus are correlated significantly with the 5-HT and 5-hydroxyindoleacetic acid levels; while Tyzzerella is correlated markedly with Glu levels. We further show that venlafaxine affected multiple functional metabolic pathways of gut bacteria in mice with CUMS-induced depression. Our results suggest that venlafaxine possibly ameliorates depression via modulating gut bacteria, and found the potential targets of its antidepressant effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai R&D Center for Standardization of Chinese Medicines, Institute of…
Förderung
- Natural Science Foundation of Shanghai
Zitieren
APA
Shen, W., Tao, Y., Zheng, F., Zhou, H., Wu, H., Shi, H., Huang, F., & Wu, X. (2023). The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114399
Vancouver
Shen W, Tao Y, Zheng F, Zhou H, Wu H, Shi H, et al. The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114399
BibTeX
@article{Shen2023,
author = {Shen, Wei and Tao, Yanlin and Zheng, Fang and Zhou, Houyuan and Wu, Hui and Shi, Hailian and Huang, Fei and Wu, Xiaojun},
title = {The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice},
journal = {Behavioural Brain Research},
year = {2023},
doi = {10.1016/j.bbr.2023.114399}
}
EUVIMED